Waldenström's macroglobulinemia surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Stem cell transplant is used in patients whose lymphoma relapses or is not responding to other treatments (refractory). <ref name="PHARM">Waldenström's macroglobulinemia. Medscape (2015)http://emedicine.medscape.com/article/2057687-overview Accessed on November 11, 2015</ref> | Stem cell transplant is used in patients whose lymphoma relapses or is not responding to other treatments (refractory). <ref name="PHARM">Waldenström's macroglobulinemia. Medscape (2015)http://emedicine.medscape.com/article/2057687-overview Accessed on November 11, 2015</ref> | ||
==Surgery== | ==Surgery== |
Revision as of 18:30, 18 November 2015
Waldenström's macroglobulinemia Microchapters |
Differentiating Waldenström's macroglobulinemia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Waldenström's macroglobulinemia surgery On the Web |
American Roentgen Ray Society Images of Waldenström's macroglobulinemia surgery |
Directions to Hospitals Treating Waldenström's macroglobulinemia |
Risk calculators and risk factors for Waldenström's macroglobulinemia surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Stem cell transplant is used in patients whose lymphoma relapses or is not responding to other treatments (refractory). [1]
Surgery
- Stem cell transplant is used in patients whose lymphoma relapses or is not responding to other treatments (refractory). [1]
References
- ↑ 1.0 1.1 Waldenström's macroglobulinemia. Medscape (2015)http://emedicine.medscape.com/article/2057687-overview Accessed on November 11, 2015